HLA-DQA1遗传变异与二肽基肽酶-4抑制剂诱发性大疱性类天疱疮的关联
该研究通过全基因组关联分析(GWAS)和HLA精细定位,探讨HLA-DQA1遗传变异与二肽基肽酶-4抑制剂(DPP-4i)诱导的非炎症性大疱性类天疱疮(BP)的关联。合并分析显示HLA-DQA1(rs3129763)等位基因T携带者在病例组占72.4%(21/29),对照组占15.3%(138/901),显性模型OR=14,P=1.8×10^-9;HLA-DQA1*05(HLA-DQα1第75位丝氨酸)关联更显著(病例组79.3%[23/29] vs 对照组16.1%[145/901],OR=21,P=2.0×10^-10)。
要点
- HLA-DQA1 rs3129763等位基因T与DPP-4i诱导的非炎症性BP风险相关(OR=14)。
- HLA-DQA1*05(HLA-DQα1 Ser75)关联最强(OR=21)。
- HLA-DQα1 Ser75位于HLA-DQ分子功能口袋内,提示其影响疾病发生。
核心结论
- HLA-DQA1(rs3129763)及HLA-DQA1*05(HLA-DQα1 Ser75)与DPP-4i诱导的非炎症性BP风险显著关联。
研究设计与样本
- 研究纳入第一队列21例DPP-4i诱导的非炎症性BP和737例对照,第二队列8例和164例对照,进行GWAS和HLA精细定位分析。
主要发现
- 合并GWAS显示HLA-DQA1 rs3129763等位基因T携带者在病例组占72.4%(21/29),对照组占15.3%(138/901),显性模型OR=14,P=1.8×10^-9。
- HLA精细定位显示HLA-DQA1*05(HLA-DQα1 Ser75)在病例组占79.3%(23/29),对照组占16.1%(145/901),显性模型OR=21,P=2.0×10^-10。
- HLA-DQα1 Ser75多态性位于HLA-DQ分子功能口袋内,提示其影响DPP-4i诱导的非炎症性BP。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bullous pemphigoid (BP) is the most common autoimmune blistering disorder. Several factors, including an antidiabetic (dipeptidyl peptidase-4 inhibitor [DPP-4i]), have been reported to trigger BP. To identify the genetic variants associated with BP, GWAS and HLA fine-mapping analyses were conducted. The 21 cases of noninflammatory BP induced by DPP-4i (i.e., DPP-4i-induced noninflammatory BP) and 737 controls (first cohort) and the 8 cases and 164 controls (second cohort) were included in the GWAS. Combining GWAS satisfied the genome-wide significant association of HLA-DQA1 (chromosome 6, rs3129763 [T/C]) with the risk of DPP-4i-induced noninflammatory BP (allele T carrier of 72.4% [21 of 29] in cases vs. 15.3% [138 of 901] in controls; dominant model, OR = 14, P = 1.8 × 10-9). HLA fine mapping revealed that HLA-DQA1∗05 with serine at position 75 of HLA-DQα1 (Ser75) had the most significant association with the combined cohort of DPP-4i-induced noninflammatory BP (79.3% [23 of 29] cases vs. 16.1% [145 of 901] controls; dominant model, OR = 21, P = 2.0 × 10-10). HLA-DQα1 Ser75 polymorphism was located inside the functional pocket of HLA-DQ molecules, suggesting the impact of HLA-DQα1 Ser75 on DPP-4i-induced noninflammatory BP.
引用
- Ozeki T, Muramatsu K, Yoshimoto N, et al. Association of Genetic Variants of HLA-DQA1 with Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors. J Invest Dermatol. 2023. PMID: 37156394. doi:10.1016/j.jid.2023.04.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。